The Nation - News from Sept. 5, 1986

Researchers reported that powerful anti-cancer drugs along with breast cancer surgery can delay relapse and increase survival rates over surgery alone. The Harvard School of Public Health, pooling data from nearly 10,000 patients, found that relapse-free survival rates of operable breast cancer were 12.5% better at three years when chemotherapy was given in addition to surgery. The American Cancer Society estimates that 123,000 new cases of breast cancer will be diagnosed in the nation this year.